Stopping of adalimumab in juvenile idiopathic arthritis-associated uveitis (ADJUST): a ...Part 2

Stopping of adalimumab in juvenile idiopathic arthritis-associated uveitis (ADJUST): a ...Part 2

From AAOF Clinical Podcast Series by American Academy of Optometry Foundation

October 6, 2025 · 8 min

About this episode

This episode discusses the findings of a clinical trial on stopping adalimumab in patients with juvenile idiopathic arthritis-associated uveitis.

Stopping of adalimumab in juvenile idiopathic arthritis-associated uveitis (ADJUST): a multicentre, double-masked, randomised controlled trial-part 2 Hosted by: Mile Brujic, OD, FAAO Topical Editor: Stephanie Martich, OD, FAAO Topical Expert: Valerie Baca, OD, FAAO Publication: https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2024.1417814/full

People in this episode

Hosts: Mile Brujic, OD, FAAO, Stephanie Martich, OD, FAAO, Valerie Baca, OD, FAAO

Topics covered

  • adalimumab
  • juvenile idiopathic arthritis
  • uveitis
  • clinical trial
  • ophthalmology

Keywords

  • adalimumab
  • juvenile idiopathic arthritis
  • uveitis
  • clinical trial
  • ophthalmology
  • randomised controlled trial
  • multicentre study

Mentioned in this episode

Organizations: American Academy of Optometry Foundation

Books & works: Stopping of adalimumab in juvenile idiopathic arthritis-associated uveitis (ADJUST): a multicentre, double-masked, randomised controlled trial-part 2, https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2024.1417814/full

More episodes of AAOF Clinical Podcast Series

Explore listener stats, chart rankings, contacts and more on the AAOF Clinical Podcast Series podcast page.